The Effect of the Timing of Colloid and Crystalloid Infusions on Postspinal Hypotension After Spinal Anesthesia for Caesarian Section

NCT ID: NCT02680678

Last Updated: 2020-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevention of postspinal hypotension after spinal anesthesia for caesarian section by use of preoperative or intraoperative volume replacement. The comparison of crystalloid and colloid infusions and their timing via perfusion index and plethysmographic variability index.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To Prevent hypotension fluid replacement is usually used in pregnant patients scheduled for C/S. Different types of fluids can be used in order to achieve this. Also the timing of fluid replacement is important. In the present study patients were separated into 4 groups. Each receiving a one of two fluids in different times. ( Colloid pre-load, colloid co-load, crystalloid co-load and crystalloid pre-load.) The effect of overall hemodynamics and the incidence of hypotension are evaluated. Also peripheric monitors like perfusion index and plethysmographic variability index are evaluated for correlation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complications; Anesthesia, Spinal and Epidural, in Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

4 group of patients were sheduled to receive either kristalloid or kolloid two gropus before and two groups during anesthesia induction
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
the outcome accessor and care provider will be aware in which gropu the patient was

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Colloid preload

20 patients each patient receives 7 ml/kg of gelatin solution (gelofusin) 15 minutes before spinal anesthesia.

Group Type ACTIVE_COMPARATOR

Colloid Preload

Intervention Type OTHER

preload infusion

Colloid Co-load

20 patients each patient receives 7 ml/kg of gelatin solution (gelofusin) beginning with spinal anesthesia.

Group Type ACTIVE_COMPARATOR

colloid co-load

Intervention Type OTHER

co-load infusion

Crystalloid Preload

20 patients each patient receives 20 ml/kg of Ringer's lactate solution 15 minutes before spinal anesthesia.

Group Type ACTIVE_COMPARATOR

Crystalloid preload

Intervention Type OTHER

preload infusion

Crystalloid Co-load

20 patients each patient receives 20 ml/kg of Ringer's lactate solution beginning with spinal anesthesia.

Group Type ACTIVE_COMPARATOR

Crystalloid Co-load

Intervention Type OTHER

co-load infusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colloid Preload

preload infusion

Intervention Type OTHER

colloid co-load

co-load infusion

Intervention Type OTHER

Crystalloid preload

preload infusion

Intervention Type OTHER

Crystalloid Co-load

co-load infusion

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Gelofusin gelofusin Ringers lactate solution Ringers lactate solution

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant 37-41 weeks
* one fetus
* scheduled for C/S under spinal anesthesia
* accepting to participate

Exclusion Criteria

* Emergency surgery
* placenta previa
* preeclampsia
* cardiovascular and cerebrovascular comorbidities
* morbid obesity (BMI\>40)
* pregnancy weeks \<36 and \> 41
* The use of vasoconstrictors
* Severe Anemia ( Hb \<9 g/dl)
* Refusal or known contraindication for spinal anesthesia
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Balikesir University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

hafize fisun demir

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hafize Fisun Demir

Role: PRINCIPAL_INVESTIGATOR

Balikesir University School of Medicine Department of Anesthesia and Reanimation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Balikesir University Faculty of Medicine

Balıkesir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BAU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.